Business Description
Sybleu Inc
NAICS : 541714
SIC : 2833
ISIN : US87114K1051
Description
Sybleu Inc engages primarily in the development of regenerative medical applications. Its principal product comprises Cell Transplant IP which comprises methods, devices, and techniques useful for enhancing the function of a cellular graft through photoceutical manipulation.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -1.28 | |||||
| Debt-to-Equity | -1.25 | |||||
| Debt-to-EBITDA | -1.79 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -6.88 | |||||
| Beneish M-Score | -3.55 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 99.37 | |||||
| 9-Day RSI | 89.84 | |||||
| 14-Day RSI | 71.69 | |||||
| 6-1 Month Momentum % | -51.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.04 | |||||
| Quick Ratio | 0.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -93.3 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -2366.67 | |||||
| Net Margin % | -2566.67 | |||||
| FCF Margin % | -700 | |||||
| ROA % | -147.65 | |||||
| ROIC % | -80.91 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 38.5 | |||||
| EV-to-EBIT | -2.69 | |||||
| EV-to-EBITDA | -2.79 | |||||
| EV-to-Revenue | 63.67 | |||||
| EV-to-FCF | -9.1 | |||||
| Earnings Yield (Greenblatt) % | -37.17 | |||||
| FCF Yield % | -20.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SYBE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sybleu Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.012 | ||
| EPS (TTM) ($) | -0.025 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 71.69 | ||
| 14-Day ATR ($) | 0.003545 | ||
| 20-Day SMA ($) | 0.02025 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0.011 - 0.15 | ||
| Shares Outstanding (Mil) | 10.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sybleu Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sybleu Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sybleu Inc Frequently Asked Questions
What is Sybleu Inc(SYBE)'s stock price today?
The current price of SYBE is $0.04. The 52 week high of SYBE is $0.15 and 52 week low is $0.01.
When is next earnings date of Sybleu Inc(SYBE)?
The next earnings date of Sybleu Inc(SYBE) is .
Does Sybleu Inc(SYBE) pay dividends? If so, how much?
Sybleu Inc(SYBE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers